Extracellular vesicles derived from cardiosphere-derived cells as a potential antishock therapeutic
- PMID: 34108422
- DOI: 10.1097/TA.0000000000003218
Extracellular vesicles derived from cardiosphere-derived cells as a potential antishock therapeutic
Abstract
Background: Extracellular vesicles (EVs) isolated from cardiosphere-derived cells (CDC-EVs) are coming to light as a unique cell-free therapeutic. Because of their novelty, however, there still exist prominent gaps in knowledge regarding their therapeutic potential. Herein the therapeutic potential of CDC-EVs in a rat model of acute traumatic coagulopathy induced by multiple injuries and hemorrhagic shock is outlined.
Methods: Extracellular vesicle surface expression of procoagulant molecules (tissue factor and phosphatidylserine) was evaluated by flow cytometry. Extracellular vesicle thrombogenicity was tested using calibrated thrombogram, and clotting parameters were assessed using a flow-based adhesion model simulating blood flow over a collagen-expressing surface. The therapeutic efficacy of EVs was then determined in a rat model of acute traumatic coagulopathy induced by multiple injuries and hemorrhagic shock.
Results: Extracellular vesicles isolated from cardiosphere-derived cells are not functionally procoagulant and do not interfere with platelet function. In a rat model of multiple injuries and hemorrhagic shock, early administration of EVs significantly reduced the elevation of lactate and creatinine and did not significantly enhance coagulopathy in rats with acute traumatic coagulopathy.
Conclusion: The results of this study are of great relevance to the development of EV products for use in combat casualty care, as our studies show that CDC-EVs have the potential to be an antishock therapeutic if administered early. These results demonstrate that research using CDC-EVs in trauma care needs to be considered and expanded beyond their reported cardioprotective benefits.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Payal P, Sonu G, Anil GK, Prachi V. Management of polytrauma patients in emergency department: an experience of a tertiary care health institution of northern India. World J Emerg Med . 2013;4(1):15–19.
-
- Wu X, Darlington DN, Cap AP. Procoagulant and fibrinolytic activity after polytrauma in rat. Am J Physiol Regul Integr Comp Physiol . 2016;310(4):R323–R329.
-
- Choi JY, Lee WH, Yoo TK, Park I, Kim DW. A new severity predicting index for hemorrhagic shock using lactate concentration and peripheral perfusion in a rat model. Shock . 2012;38(6):635–641.
-
- Mevius H, van Dijk M, Numanoglu A, van As AB. The management of pediatric polytrauma: review. Clin Med Insights Trauma Intensiv Med . 2014;5:27–37.
-
- Chak Wah K, Wai Man C, Janet Yuen Ha W, Lai V, Kit Shing John W. Evolving frontiers in severe polytrauma management — refining the essential principles. Malays J Med Sci . 2013;20(1):1–12.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
